logo

For the Inventor, By the Inventor

Austin, TX, United States of America

Mati Therapeutics Inc.


USPTO Granted Patents = 37



Trademarks = 1

Forward Citations = 265

Loading Chart...
Loading Chart...

33 inventors (with patents filed for the assignee):

goldMedal Eugene De Juan, Jr (15 out of 128 patents)

silverMedal Cary J Reich (15 out of 129 patents)

bronzeMedal Alan R Rapacki (15 out of 35 patents)

4.  Stephen A Boyd (15 out of 64 patents)

5.  Hanson S Gifford, Iii (12 out of 255 patents)

6.  Mark E Deem (12 out of 123 patents)

7.  Valery Rubinchik (8 out of 12 patents)

8.  Deepank Utkhede (7 out of 8 patents)

9.  Sylvie Sim (7 out of 8 patents)

10.  John B Holds (5 out of 6 patents)

11.  Danny Shen (5 out of 7 patents)

12.  Rachna Jain (4 out of 5 patents)

13.  Eliot Lazar (4 out of 6 patents)

14.  Suzanne Cadden (3 out of 6 patents)

15.  Yong Hao (3 out of 5 patents)


37 patents:

1. 12226525 - Nasolacrimal drainage system implants for drug therapy (2025-02-18),
2. 11951038 - Lacrimal implants and related methods (2024-04-09),
3. 11712370 - Lacrimal implants and related methods (2023-08-01),
4. 11633300 - Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device (2023-04-25),
5. 11406592 - Drug delivery methods, structures, and compositions for nasolacrimal system (2022-08-09),
6. 11406532 - Static pin insertion tool for lacrimal implant (2022-08-09),
7. 11324693 - Ophthalmic drug sustained release formulation and uses thereof (2022-05-10),
8. 11141312 - Lacrimal implant detection (2021-10-12),
9. 10874606 - Nasolacrimal drainage system implants for drug therapy (2020-12-29),
10. 10632012 - Sustained release delivery of active agents to treat glaucoma and ocular hypertension (2020-04-28),
11. 10610407 - Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such delivery device (2020-04-07),
12. 10603274 - Ophthalmic drug sustained release formulation and uses thereof (2020-03-31),
13. 10434009 - Lacrimal implants and related methods (2019-10-08),
14. 10383817 - Nasolacrimal drainage system implants for drug therapy (2019-08-20),
15. 10300014 - Nasolacrimal drainage system implants for drug therapy (2019-05-28),
Mati Therapeutics Inc. is a biopharmaceutical company developing innovative ocular treatments. Our mission is to improve the lives of patients suffering from ocular diseases through the development of novel therapies. By leveraging cutting-edge technologies, we aim to provide effective and convenient solutions for a range of ocular conditions. Visit our website to learn more about our pipeline and ongoing research endeavors.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

37 Patents

#78 in Austin, TX

#508 in Texas

#8,949 in US

#17,726 in the World

...
Austin, TX, United States of America

Mati Therapeutics Inc.

Forward Citations = 265

33 inventors:

goldMedal Eugene De Juan, Jr (15 out of 128 patents)

silverMedal Cary J Reich (15 out of 129 patents)

bronzeMedal Alan R Rapacki (15 out of 35 patents)

4.  Stephen A Boyd (15 out of 64 patents)

5.  Hanson S Gifford, Iii (12 out of 255 patents)

Please report any incorrect information to support@idiyas.com
Loading…